Skip to main content
Clinical Trials/NCT02438267
NCT02438267CompletedNot Applicable

Preterm Infants and Nephrocalcinosis: Diagnosis and Pathogenesis

University of Utah1 site in 1 country56 target enrollmentStarted: April 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
56
Locations
1
Primary Endpoint
Urinary calcium to creatinine ratio (UCa/Cr)

Study Overview

Brief Summary

Nephrocalcinosis (NC), defined as calcification of renal tissue, has been reported to occur in 7-41% of premature infants. Causes of NC are likely multi-factorial, and infants born prematurely and with very low birth weight (<1500 gm) seem to be at the highest risk of developing NC. Recent changes in recommendations for nutrition for the preterm infant such as higher intakes of protein, calcium, and vitamin D may also play a factor in the pathogenesis of NC.

Currently, diagnosis of NC often occurs incidentally during ultrasound evaluation for other issues. Because there is no acute symptom or pattern of symptoms in the preterm population associated specifically with NC, it is possible that many cases of NC may not be diagnosed. Presently, it is impractical and costly to screen all infants for NC with renal ultrasound, therefore there is no standard of care regarding screening for NC.

NC may have long-term effects. Studies have shown that preterm infants with NC had shorter kidneys and a lower rate of tubule resorption of phosphorus (TRP) than preterm infants without NC.

This study will analyze weekly urinalysis for all enrolled subjects prospectively and then look at the incidence of NC at discharge of the enrolled subjects.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 2 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Infants whose gestation less than or equal to 32 weeks and/or birth weights less than 1800 gm

Exclusion Criteria

  • Infants with congenital abnormalities of the heart, lung, GI, or kidneys that will affect renal function.

Outcomes

Primary Outcomes

Urinary calcium to creatinine ratio (UCa/Cr)

Time Frame: 3 months

Beginning within the first two weeks of life, urine calcium to creatinine ratio (UCa/Cr) will be analyzed weekly through discharge and then correlated to renal ultrasound results done prior to discharge.

Urinary crystals

Time Frame: 3 months

Beginning within the first two weeks of life, urinalysis for evidence of urinary crystallization will be analyzed weekly through discharge and then correlated to renal ultrasound results done prior to discharge.

Secondary Outcomes

  • Serum Vitamin D levels(3 months)
  • Vitamin D intake(3 months)
  • Total bone density per DXA(3 months)
  • Calcium intake(3 months)
  • Protein intake(3 months)
  • Tibial bone density per tibial ultrasound(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials